Ankylosis - 220 Studies Found
| Completed |
: Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis : Ankylosing Spondyloarthritis : 2015-12-16 :
|
| Active, not recruiting |
: Post-Marketing Use Of Inflectra (Infliximab) For Standard Of Care Treatment Of Rheumatoid Disease Who Are Naïve To Biologics Or Switched From Remicade™ :
|
| Active, not recruiting |
: Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE) :
: |
| Completed |
: Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) :
: 2015-08-18 : |
| Completed |
: Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA : Spondylitis, Ankylosing : 2015-07-21 : Biological: Etanercept 50 mg subcutaneous, once weekly, 24 weeks |
| Not yet recruiting |
: AL-2 MP-1 (Polyimide) Acetabular Liner :
|
| Completed |
: An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis : Nonradiographic Axial Spondylitis, Ankylosing : 2015-03-30 :
|
| Completed |
: The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis :
: 2015-03-09 :
|
| Completed |
: 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) :
: 2014-12-18 : Drug: 99mTc-rhAnnexin V-128 1 single intravenous bolus administration of 250 MBq, at Day 1 and at Day 42 |
| Enrolling by invitation |
: Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries :
: 2014-10-31 |